Neoadjuvant TherapyChemotherapy, AdjuvantEsophagectomyChemoradiotherapy, AdjuvantTreatment OutcomeRadiotherapy, AdjuvantRectal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCombined Modality TherapyNeoplasm StagingEsophageal NeoplasmsFluorouracilAdenocarcinomaTaxoidsDisease-Free SurvivalChemoradiotherapyEpirubicinPrognosisAntineoplastic AgentsDoxorubicinSarcomaCisplatinPancreatic NeoplasmsReceptor, erbB-2Neoplasm Recurrence, LocalSurvival RateAntibodies, Monoclonal, HumanizedDeoxycytidineRetrospective StudiesSurvival AnalysisPancreaticoduodenectomyPancreatectomyNomogramsCyclophosphamidePaclitaxelNeoplasm, ResidualAntineoplastic Agents, HormonalPositron-Emission TomographyLymphatic MetastasisFluorodeoxyglucose F18Prospective StudiesFollow-Up StudiesOrganoplatinum CompoundsPredictive Value of TestsKaplan-Meier EstimateCarcinoma, Squamous CellEsophagogastric JunctionTumor BurdenPreoperative CareReceptors, EstrogenTomography, X-Ray ComputedTumor Markers, BiologicalMastectomy, SegmentalRadiopharmaceuticalsCarcinoma, Pancreatic DuctalProstatectomyDrug Administration ScheduleLeucovorinAnthracyclinesTime FactorsSoft Tissue NeoplasmsCarcinomaCystectomyNeoplasm MetastasisAntibodies, MonoclonalMultivariate AnalysisBiomarkers, PharmacologicalImmunohistochemistryCarcinoma, Ductal, BreastMuscle NeoplasmsLung NeoplasmsReceptors, ProgesteroneOsteosarcomaBridged CompoundsCarcinoma, LobularVinblastineNitrilesMethotrexateKi-67 AntigenAndrogen AntagonistsMastectomyTriazolesUrinary Bladder NeoplasmsRisk Factors